Clinical trial
Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in…
NCT00238355 · OHSU Knight Cancer Institute, Other · Terminated
Key facts
| NCT number | NCT00238355 |
|---|---|
| Title | Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems |
| Official title | Phase II Trial of Voriconazole Plus Caspofungin for the Initial Treatment of Invasive Fungal Infections |
| Lead sponsor | OHSU Knight Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Infection, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | caspofungin acetate, voriconazole |
| Enrollment | 13 |
| Start date | Aug 1, 2003 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Oct 13, 2005 |
| Last update posted | Apr 27, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: